Intrauterine Contraceptive Devices Market is Expected to Reach a Value of $4,605.6 Million by 2019

The report “Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] – Global Forecast to 2019”, defines and segments the Intrauterine Contraceptive Devices Market (IUD/IUCD) with analysis and forecasting of global revenue. It also identifies the driving and restraining factors of the market with analysis of trends, opportunities, and challenges.


The copper IUCD market accounted for the maximum share of 51.9% in 2014, followed by hormonal IUCD with a share of 48.1%. The copper IUCD market is expected to reach $2,384.9 million by 2019, at a CAGR of 6.7%, and the hormonal IUCD market is expected to reach $2,222.0 million by 2019 at a CAGR of 6.9% from 2014 to 2019.

Geographically, the Asia contributed the maximum market share of around 35.0% in 2014. This market was valued at $1,161.3 million in 2014, and is expected to reach a value of $1,637.9 million by 2019, at a CAGR of 7.1% from 2014 to 2019. In terms of growth potential, the European market is an open market, and accounted for the second-largest market share of 30.1% in 2014. The European intrauterine contraceptive devices market was valued at $996.5 million in 2014, and is expected to reach $1,394.3 million by 2019, at a CAGR of 6.9% from 2014 to 2019.

Intrauterine contraceptive devices are most commonly known as IUD/IUCD. These devices are inserted into the uterus to prevent pregnancy. The IUCD can be a coil, loop, triangle, or T in shape made of plastic or metal. There are many types of IUCDs based on their shapes and sizes. They are usually made up of polypropylene saturated with barium sulfate, to visualize them on x-rays. The commonly used device is ’T’ shaped with a horizontal and vertical arm. The vertical arm has a copper wire wrapped around it and two colored nylon threads at the lower end. This thread (tail), which protrudes through the cervix into the vagina, enables the user to verify its correct placement. The hormone-releasing IUCDs available in the market are suitable for women with special needs. An IUCD is approximately 99.0% reliable in preventing pregnancy. The newer devices, such as Multi Loads ML-Cu-250, ML-Cu-375, and Cu 7 – 380 A, are highly effective, that is greater than 99.0% birth control assurance.

An IUCD is inserted into the uterus by a healthcare professional. This prevents sperms and egg from meeting by either immobilizing the sperms on their way to the fallopian tubes or by changing the uterine lining, so that the fertilized egg cannot implant in it.

The growth of the intrauterine contraceptive devices market is driven by factors such as rising rate of unplanned pregnancies, effective contraception and minimum side effects of IUCD, implementation of Affordable Care Act (ACA), higher number of initiatives undertaken by private firms directed towards reducing the expenses related to abortion, and technological advancements. For instance, the Colorado Family Planning Initiative has provided more than 30,000 intrauterine devices (IUCDs) or implants at low or no cost to low-income women at 68 family planning clinics across Colorado since 2009. The decline in births among young women served by these agencies accounted for three-quarters of the overall decline in the Colorado teen birth rate. As a result, in July 2014, the organization announced that, the teen birth rate in Colorado dropped by 40% within 2009 to 2013, driven by a Colorado Department of Public Health and Environment initiative that helps low-income women get long-acting reversible contraceptives (LARC) such as intrauterine contraceptive devices. High cost of treatment, threat of causing pelvic inflammatory infection (PID), threat of causing ectopic pregnancy, high rate of complications during unplanned pregnancy, are hindering the growth of the IUCD market.

The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals and product recalls of the major companies are detailed in the report. The main companies operating in this market are Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland) and other companies.

Report Subscription:

MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.

About MicroMarket Monitor:

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Mr. Chandrasekhar K.
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013,
India 1-888-502-0539